Explore Starodub latest resources

Top 10 Deficiencies in New Applications for a Certificate of Suitability (CEP)

Regulatory Procedure Management for Centrally Authorised Products transitions to IRIS platform

Goodbye

Are 6-month chronic toxicity studies always necessary for nonclinical safety assessment of therapeutic monoclonal antibodies?

Dutch Agency MEB expands options for Planning Tool for requesting time slots

Unlocking Potential: The Vital Role of GSPR in Medical Device Development

Our expertise

Starodub Whitepapers

Valentyna Starodub
Founder and Chief Executive Officer
Valentyna Starodub

Let's Connect

Talk to an expert